As President and CEO, Kendalle leads the strategic direction, global expansion, and business operations of the organization ensuring that MassBio offers the greatest value to its members and that Massachusetts life sciences companies have the best environment possible to research, develop, and commercialize breakthrough therapies and cures for people around the world who need and deserve them. Kendalle first came to MassBio in 2008 as Director of Purchasing and Strategic Alliance. She was promoted to Vice President of Member Services and General Counsel in 2012, then promoted to the organization’s first-ever Chief Operating Officer in February 2019. Throughout her tenure at MassBio, Kendalle has played a critical role in the growth of MassBio’s membership supporting its expansion to become the largest life sciences trade association in the world with over 1,400 members. Kendalle has overseen the rebrand of a number of MassBio’s core programs and services, including the MassBio Edge, MassBio’s savings and rewards program, and its expansion into other New England states by building valuable partnerships with the supplier community and creating MassBio’s highly-rated Employee Rewards program. She also led the development of the MassBioHub, MassBio’s conference and business center, and the creation of MassBio’s 2025 State of Possible Report. In 2019, Kendalle commenced a multi-year digital health initiative to support the convergence of digital tech and the life sciences in Massachusetts. And in 2021, Kendalle was instrumental in the launch of MassBio’s Partnering Week, a new initiative to bring together established biopharma companies with early-stage startups and academic institutions. Kendalle has reached extraordinary heights in her growing career. She was named a 2019 Boston Business Journal 40 under 40 honoree which recognizes a leader’s impact on Massachusetts’ industries.